ATC Group: V08AB07 Ioversol

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V08AB07 in the ATC hierarchy

Level Code Title
1 V Various
2 V08 Contrast media
3 V08A X-ray contrast media, iodinated
4 V08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media
5 V08AB07 Ioversol

Active ingredients in V08AB07

Active Ingredient Description
Ioversol

Ioversol is a non-ionic X-ray contrast medium. Intravascular injection of ioversol opacifies those vessels in the path of the flow of the contrast medium, permitting radiographic visualisation of the internal structures until significant haemodilution occurs.

Related product monographs

Title Information Source Document Type  
OPTIRAY Solution for injection or infusion Health Products Regulatory Authority (IE) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Ecuador (EC)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Japan (JP)

New Zealand (NZ)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.